首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
【24h】

Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.

机译:儿童肾病综合征慢性环孢素肾病中肾素活性的免疫组织化学分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Although the pivotal role of activation of the intrarenal renin-angiotensin system (RAS) has been demonstrated in the rat model of chronic cyclosporine (CyA) nephropathy, it is still unclear whether intrarenal RAS activation is responsible for chronic CyA nephropathy in humans. Therefore, the distribution of renin in formalin-fixed, paraffin-embedded renal biopsy specimens obtained from 26 children who had idiopathic nephrotic syndrome (NS) and who were treated with long-term moderate-dose CyA was examined with the use of immunohistochemistry with rabbit polyclonal anti-human renin antibody. Nineteen patients had steroid-dependent NS, and 7 had steroid-resistant NS. However, CyA treatment led all of the latter patients into complete remission. All of the patients underwent renal biopsies at the start and the end of CyA treatment. In the pre-CyA specimens, immunoreactivity to renin was detected mainly in those parts of arterioles within the anatomically well-defined juxtaglomerular apparatus. In the post-CyA specimens, it was also detected in those parts of the vessels upstream from the juxtaglomerular apparatus. Moreover, the ratio of the number of renin-positive cells to the number of glomeruli (histologic renin index) increased significantly with long-term CyA treatment (from 1.26+/-0.24 to 4.30+/-0.40, P<0.0001). Eleven of the post-CyA specimens showed mild or moderate CyA-associated arteriolopathy (CAA), whereas 15 showed no CAA. The histologic renin index was significantly higher in specimens with CAA than in those without CAA (5.16+/-0.59 versus 3.67+/-0.48, P = 0.031). Seven CAA-positive patients underwent repeat biopsies 6 to 12 mo after discontinuing the CyA. Their specimens showed an improvement in the CAA and significantly lower histologic renin index compared with the post-CyA (from 4.18+/-0.69 to 2.10+/-0.25, P = 0.018). Eleven of the post-CyA specimens showed mild to moderate interstitial fibrosis, and 15 showed no fibrosis. There was no significant difference in immunoreactivity to renin between the specimens with interstitial fibrosis and those without. However, patients with interstitial fibrosis had significantly longer periods of heavy proteinuria during CyA therapy, because of either steroid-resistant NS or frequent relapses of NS (83+/-18 versus 35+/-12 d, P = 0.030). These findings indicate that long-term CyA treatment for idiopathic NS in children may stimulate renin production in arterioles. They also suggest that CyA-stimulated intrarenal RAS activation is responsible for the development of CAA and that CyA-induced interstitial fibrosis is potentiated by long-term heavy proteinuria and is at least partly independent of CyA-stimulated intrarenal RAS activation.
机译:尽管已经在慢性环孢素(CyA)肾病的大鼠模型中证明了肾内肾素-血管紧张素系统(RAS)激活的关键作用,但仍不清楚肾内RAS激活是否对人类慢性CyA肾病负责。因此,采用免疫组化技术对兔进行了福尔马林固定,石蜡包埋的肾活检标本中肾素的分布,这些标本取自26名患有特发性肾病综合征(NS)并接受长期中剂量CyA治疗的儿童多克隆抗人肾素抗体。 19名患者患有类固醇依赖性NS,7名患者患有类固醇抵抗性NS。但是,CyA治疗使所有后者患者完全缓解。所有患者在CyA治疗开始和结束时均接受了肾脏活检。在CyA之前的样本中,主要在解剖学明确的近肾小球装置内的那些小动脉部位检测到了针对肾素的免疫反应性。在CyA后的样本中,在近肾小管装置上游的那些血管部分也检测到了它。此外,长期使用CyA治疗后,肾素阳性细胞数量与肾小球数量的比率(组织学肾素指数)显着增加(从1.26 +/- 0.24增至4.30 +/- 0.40,P <0.0001)。 CyA后的标本中有11个显示出轻度或中度的CyA相关性动脉病(CAA),而15个则没有显示。有CAA的标本的组织学肾素指数显着高于没有CAA的标本(5.16 +/- 0.59对3.67 +/- 0.48,P = 0.031)。 7名CAA阳性患者在终止CyA后6至12个月重复活检。与CyA后相比,他们的标本显示出CAA的改善和组织学肾素指数显着降低(从4.18 +/- 0.69到2.10 +/- 0.25,P = 0.018)。 CyA后的标本中有11个显示出轻度至中度的间质纤维化,而15个没有显示纤维化。间质纤维化的标本与无间质纤维化的标本对肾素的免疫反应性无显着差异。然而,由于类固醇抵抗性NS或NS复发频繁,间质纤维化患者在CyA治疗期间出现重度蛋白尿的时间明显更长(83 +/- 18与35 +/- 12 d,P = 0.030)。这些发现表明,对儿童特发性NS进行长期CyA治疗可能会刺激小动脉中的肾素生成。他们还表明,CyA刺激的肾内RAS激活是CAA发生的原因,而CyA诱导的间质纤维化可通过长期的重蛋白尿而增强,并且至少部分独立于CyA刺激的肾内RAS激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号